Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.2)
Main Sectors:
Top Industries:
39 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ASMB Assembly Biosciences | Assumes: Buy | 50 | 23.32 | 114.41% | 1 | Aug 18, 2025 | |
ALT Altimmune | Reiterates: Buy | 12 12 | 3.91 | 206.91% | 19 | Aug 13, 2025 | |
ALNY Alnylam Pharmaceutic... | Maintains: Strong Buy | 500 570 | 456.35 | 24.9% | 27 | Aug 7, 2025 | |
CMPS Compass Pathways | Maintains: Buy | 45 40 | 6.43 | 522.08% | 17 | Aug 4, 2025 | |
ATAI ATAI Life Sciences | Maintains: Strong Buy | 10 15 | 5.23 | 186.81% | 20 | Jul 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 6.9 | 44.93% | 2 | Jun 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 1.16 | 331.03% | 19 | Jun 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 0.68 | 1370.59% | 26 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 75 75 | 5 | 1400% | 24 | Jun 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 100 100 | 34.21 | 192.31% | 21 | Jun 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 70 70 | 54.92 | 27.46% | 15 | May 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 1.38 | 262.32% | 18 | May 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 60 60 | 5.44 | 1002.94% | 18 | May 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 36.12 | 121.48% | 23 | May 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 40 | 13.1 | 205.34% | 15 | May 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 4.86 | 517.28% | 10 | Apr 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 70 70 | 27.28 | 156.6% | 6 | Apr 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 25.75 | 210.68% | 8 | Apr 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 10 | 2.11 | 373.93% | 19 | Apr 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 2.57 | 289.11% | 16 | Mar 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 55 55 | 12.56 | 337.9% | 18 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 110 110 | 5.73 | 1819.72% | 23 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 85 85 | 53.26 | 59.59% | 2 | Feb 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 190 150 | 6.07 | 2371.17% | 17 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 60 | n/a | n/a | 14 | Oct 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 15 7 | n/a | n/a | 8 | Nov 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 360 | n/a | n/a | 5 | May 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 2 | Mar 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 | n/a | n/a | 1 | Feb 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 3 | n/a | n/a | 2 | Feb 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | n/a | n/a | 1 | Oct 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 170 68 | 13.84 | 391.33% | 2 | Sep 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 7 | n/a | n/a | 4 | Jul 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 120 100 | n/a | n/a | 3 | Feb 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 230 20 | n/a | n/a | 2 | Dec 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 500 625 | n/a | n/a | 2 | Nov 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 10 | n/a | n/a | 3 | Oct 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 260 340 | 183.57 | 85.22% | 1 | Aug 18, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | n/a | n/a | 1 | Jul 26, 2021 |